Delaware | 03-0491827 |
(State of Incorporation or Organization) |
(I.R.S. Employer
Identification no.) |
9605 Medical Center Drive, Suite 300,
Rockville, MD |
20850 |
(Address of Principal Executive Offices) | (Zip Code) |
If this form relates to the
registration of a class of
securities pursuant to Section
12(b) of the Exchange Act and is
effective pursuant to General
Instruction A.(c), please check
the following box.
¨
|
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. x |
Securities Act registration statement file number to which this form relates: | 333-130759 |
(If Applicable) |
Title of Each Class
to be so Registered |
Name of Each Exchange on Which Each
Class is to be Registered |
Not Applicable | Not Applicable |
1.1*
|
Second Restated Certificate of Incorporation of the Registrant | |
|
||
1.2*
|
Certificate of Amendment of the Second Restated Certificate of Incorporation of the Registrant dated March 22, 2005 | |
|
||
1.3*
|
Certificate of Amendment of the Second Restated Certificate of Incorporation of the Registrant dated December 9, 2005 | |
|
||
1.4*
|
Certificate of Correction to the Certificate of Amendment of the Second Restated Certificate of Incorporation of the Registrant dated December 9, 2005 | |
|
||
1.5*
|
Certificate of Amendment to the Second Restated Certificate of Incorporation of the Registrant to take effect as of the effectiveness of the S-1 Registration Statement | |
|
||
1.6*
|
Form of Amended and Restated Certificate of Incorporation of the Registrant to take effect as of the closing of the offering | |
|
||
1.7*
|
Bylaws of the Registrant | |
|
||
1.8*
|
Form of Amended and Restated Bylaws of the Registrant to take effect as of the closing of the offering | |
|
||
1.9*
|
Specimen certificate representing the common stock of the Registrant | |
|
||
1.10*
|
2004 Securityholder Agreement |
* | Filed as an exhibit to the S-1 Registration Statement and incorporated herein by reference |
Dated: March 28, 2006 | VANDA PHARMACEUTICALS INC. | |||
|
||||
|
||||
|
By: | /s/ Mihael Polymeropoulos | ||
|
||||
|
Name: | Mihael Polymeropoulos | ||
|
Title: | President & Chief Executive Officer |
Exhibit | ||
Number | Description | |
|
||
1.1*
|
Second Restated Certificate of Incorporation of the Registrant | |
|
||
1.2*
|
Certificate of Amendment of the Second Restated Certificate of Incorporation of the Registrant dated March 22, 2005 | |
|
||
1.3*
|
Certificate of Amendment of the Second Restated Certificate of Incorporation of the Registrant dated December 9, 2005 | |
|
||
1.4*
|
Certificate of Correction to the Certificate of Amendment of the Second Restated Certificate of Incorporation of the Registrant dated December 9, 2005 | |
|
||
1.5*
|
Certificate of Amendment to the Second Restated Certificate of Incorporation of the Registrant to take effect as of the effectiveness of the S-1 Registration Statement | |
|
||
1.6*
|
Form of Amended and Restated Certificate of Incorporation of the Registrant to take effect as of the closing of the offering | |
|
||
1.7*
|
Bylaws of the Registrant | |
|
||
1.8*
|
Form of Amended and Restated Bylaws of the Registrant to take effect as of the closing of the offering | |
|
||
1.9*
|
Specimen certificate representing the common stock of the Registrant | |
|
||
1.10*
|
2004 Securityholder Agreement |
* | Filed as an exhibit to the S-1 Registration Statement and incorporated herein by reference |